Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum

Archives of Dermatology

Volumn 140, Issue 8, 2004, Pages 931-936

  Ayoub, Nakhlé ^a   Charuel, Jean Luc ^a   Diemert, Marie Claude ^a   Barete, Stéphane ^a   André, Marc ^b   Fermand, Jean Paul ^c   Piette, Jean Charles ^a   Francès, Camille ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FORMALDEHYDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; ERYTHEMA ELEVATUM DIUTINUM; EVALUATION; FEMALE; FRANCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKOCYTOCLASTIC VASCULITIS; MALE; NEUTROPHIL; NEUTROPHILIC DERMATOSIS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CASE-CONTROL STUDIES; ERYTHEMA; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; SKIN DISEASES, VASCULAR; SWEET'S SYNDROME;

EID: 4043165694     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.8.931     Document Type: Article

References (37)

1. Ylannias JA, el-Azhary RA, Gibson LE. Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients. J Am Acad Dermatol. 1992;26:38-44.
2. LeBoit PE, Yen TS, Wintroub B. The evolution of lesions in erythema elevatum diutinum. Am J Dermatopathol. 1986;8:392-402.
3. Wilkinson SM, English JS, Smith NP, Wilson-Jones E, Winkelmann RK. Erythema elevatum diutinum: a clinicopathological study. Clin Exp Dermatol. 1992; 17:87-93.
4. Grabbe J, Haas N, Moller A, Henz BM. Erythema elevatum diutinum-evidence for disease-dependent leucocyte alterations and response to dapsone. Br J Dermatol. 2000;143:415-420.
5. Bayle P, Laplanche G, Gorguet B, Oksman F, Boulinguez S, Bazex J. Neutrophilic dermatosis: a case of overlapping syndrome with monoclonal antineutrophil cytoplasmic autoantibody activity. Dermatology. 1994;189:69-71.
6. Rovel-Guitera P, Diemert MC, Charuel JL, et al. IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis. Br J Dermatol. 2000;143:99-103.
7. Callen JP. Pyoderma gangrenosum. Lancet. 1998;351:581-585.
8. Kemmett D, Harrison DJ, Hunter JA. Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol. 1991;24: 967-969.
9. Kemmett D, Hunter JA. Sweet's syndrome: a clinicopathologic review of twentynine cases. J Am Acad Dermatol. 1990;23:503-507.
10. Faber V, Elling P, Norup G. An antinuclear factor specific for leukocytes. Lancet. 1964;2:344-345.
11. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989;6:12-13.
12. Wiik A. Rational use of ANCA in the diagnosis of vasculitis. Rheumatology (Oxford). 2002;41:481-483.
13. Lock RJ. ACP Broadsheet No 143: January 1994: detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol. 1994;47:4-8.
14. Hagen EC. Development and standardization of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation study. Clin Exp Immunol. 1995;101(suppl 1):29.
15. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41:1521-1537.
16. Pudifin DJ, Duursma J, Gathiram V, Jackson TF. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Clin Exp Immunol. 1994;97:48-51.
17. Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum. 2000;43:226-231.
18. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43:405-413.
19. Keogan MT, Esnault VL, Green AJ, Lockwood CM, Brown DL. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol. 1992; 90:228-234.
20. Ballieux BE, Zondervan KT, Kievit P, et al. Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC? Clin Exp Immunol. 1994;97:52-60.
21. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or antimyeloperoxidase antibodies. Blood. 1995;86:3189-3195.
22. Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage CO. IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin Exp Immunol. 1996;106:273-279.
23. Radford DJ, Luu NT, Hewins P, Nash GB, Savage CO. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum. 2001;44:2851-2861.
24. Thomas DM, Moore R, Donovan K, Wheeler DC, Esnault VL, Lockwood CM. Pulmonary-renal syndrome in association with anti-GBM and IgM ANCA [letter]. Lancet. 1992;339:1304.
25. Esnault VL, Soleimani B, Keogan MT, Brownlee AA, Jayne DR, Lockwood CM. Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage. Kidney Int. 1992;41:1304-1310.
26. Ronda N, Esnault VL, Layward L, et al. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol. 1994;95: 49-55.
27. Mahadeva R, Dunn AC, Westerbeek RC, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol. 1999;117:561-567.
28. Gigase P, De Clerck LS, Van Cotthem KA, et al. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease with special attention for IgA-class antibodies. Dig Dis Sci. 1997;42:2171-2174.
29. Hansen U, Haerslev T, Knudsen B, Jacobsen GK. Erythema elevatum diutinum: case report showing an unusual distribution. Cutis. 1994;53:124-126.
30. Porneuf M, Duterque M, Sotto A, Jourdan J. Unusual erythema elevatum diutinum with fibrohistiocytic proliferation. Br J Dermatol. 1996;134:1131-1134.
31. Shanks JH, Banerjee SS, Bishop PW, Pearson JM, Eyden BP. Nodular erythema elevatum diutinum mimicking cutaneous neoplasms. Histopathology. 1997;31: 91-96.
32. von den Driesch P, Weber MF. Are antibodies to neutrophilic cytoplasmic antigens (ANCA) a serologic marker for Sweet's syndrome [letter]? J Am Acad Dermatol. 1993;29:666.
33. Burrows NP. Anti-neutrophil cytoplasmic antibodies in Sweet's syndrome. J Am Acad Dermatol. 1994;31:825-826.
34. Chow RK, Benny WB, Coupe RL, Dodd WA, Ongley RC. Erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with intermittent plasma exchange. Arch Dermatol. 1996;132:1360-1364.
35. Katz SI, Gallin JI, Hertz KC, Fauci AS, Lawley TJ. Erythema elevatum diutinum: skin and systemic manifestations, immunologic studies, and successful treatment with dapsone. Medicine (Baltimore). 1977;56:443-455.
36. Wolf R, Tuzun B, Tuzun Y. Dapsone: unapproved uses or indications. Clin Dermatol. 2000;18:37-53.
37. Jethwa HS, Nachman PH, Falk RJ, Jennette JC. False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. Clin Exp Immunol. 2000;121:544-550.